DIZE, by acting as an ACE2 activator, exerts a reno-protective effect in MetS rats through downregulation of the renal TLR4–NF-κB pathway, thereby mediating renal anti-inflammatory and antioxidant properties. Here, TLR4 is linked to metabolic syndrome.